Ignelzi Troy A. 4
4 · Contineum Therapeutics, Inc. · Filed May 20, 2024
Insider Transaction Report
Form 4
Ignelzi Troy A.
Director
Transactions
- Award
Stock Option (right to buy)
2024-05-20+23,150→ 23,150 totalExercise: $15.71Exp: 2034-05-19→ Class A Common Stock (23,150 underlying)
Footnotes (1)
- [F1]Options granted under the Issuer's 2024 Equity Incentive Plan, pursuant to the Issuer's Non-Employee Director Compensation Plan. One-third of the option shares vest and become exercisable on May 20, 2025, and the remainder vests in 24 equal monthly installments thereafter, subject to the Reporting Person's continuous service.